Abstract
Benzazolo[3,2-a]quinolium salts (BQS) are cationic quaternary alkaloids with similar structure to the anticancer agent ellipticine. This study describes the synthesis and screen, at the experimental concentration of 10 mM, utilizing the 60 cell line anti-cancer screening of two BQS, namely, 7-benzyl-3- aminobenzimidazo[3,2-a]quinolinium chloride (ABQ-48: NSC D-763307) and the corresponding 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium chloride (NBQ 48: NSC D-763303). Compound ABQ-48: NSC D-763307 was also screened in the 5-dose NCI panel. These compounds differ in the presence of an amino or nitro substituent at the 3- position in ring A. The data show that ABQ 48 with electron donating amino group at position 3 in ring A is highly effective in the growth inhibition in several cancer cell lines. However, its analog NBQ 48 which has an electron withdrawing nitrogen group at this position has negligible effect in most of the cell lines. In particular, ABQ 48 shows >90% growth inhibition in KM12, U251 & SK-MEL-5; and >70% growth inhibition in several cell lines. As per the NCI’s screening criteria ABQ 48 showed better than 60% growth inhibition in at least eight tumor cell lines, and thus, selected for the five dose response study. It is therefore concluded that the biological activity of these compounds is greatly affected by their electron donating properties. Additionally, this work describes the complete proton and carbon-13 chemical shifts assignments using 1D and 2D nuclear magnetic resonance techniques.
Keywords: Cancer, quinolinium salts, synthesis.
Current Bioactive Compounds
Title:Synthesis of and Biological Study of 7-Benzyl-3-aminobenzimidazo[3,2- a]quinolinium Chloride (ABQ-48: NSC D-763307) and 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium Chloride (NBQ 48: NSC D-763303)
Volume: 10 Issue: 4
Author(s): Osvaldo Cox, Christian Velez, Vineet Kumar, Sanjay V. Malhotra, Luis A. Rivera, Wigberto J. Hernandez, Jose R. Martinez, Marisol Cordero and Beatriz Zayas
Affiliation:
Keywords: Cancer, quinolinium salts, synthesis.
Abstract: Benzazolo[3,2-a]quinolium salts (BQS) are cationic quaternary alkaloids with similar structure to the anticancer agent ellipticine. This study describes the synthesis and screen, at the experimental concentration of 10 mM, utilizing the 60 cell line anti-cancer screening of two BQS, namely, 7-benzyl-3- aminobenzimidazo[3,2-a]quinolinium chloride (ABQ-48: NSC D-763307) and the corresponding 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium chloride (NBQ 48: NSC D-763303). Compound ABQ-48: NSC D-763307 was also screened in the 5-dose NCI panel. These compounds differ in the presence of an amino or nitro substituent at the 3- position in ring A. The data show that ABQ 48 with electron donating amino group at position 3 in ring A is highly effective in the growth inhibition in several cancer cell lines. However, its analog NBQ 48 which has an electron withdrawing nitrogen group at this position has negligible effect in most of the cell lines. In particular, ABQ 48 shows >90% growth inhibition in KM12, U251 & SK-MEL-5; and >70% growth inhibition in several cell lines. As per the NCI’s screening criteria ABQ 48 showed better than 60% growth inhibition in at least eight tumor cell lines, and thus, selected for the five dose response study. It is therefore concluded that the biological activity of these compounds is greatly affected by their electron donating properties. Additionally, this work describes the complete proton and carbon-13 chemical shifts assignments using 1D and 2D nuclear magnetic resonance techniques.
Export Options
About this article
Cite this article as:
Cox Osvaldo, Velez Christian, Kumar Vineet, V. Malhotra Sanjay, A. Rivera Luis, J. Hernandez Wigberto, R. Martinez Jose, Cordero Marisol and Zayas Beatriz, Synthesis of and Biological Study of 7-Benzyl-3-aminobenzimidazo[3,2- a]quinolinium Chloride (ABQ-48: NSC D-763307) and 7-benzyl-3- nitrobenzimidazo[3,2-a]quinolinium Chloride (NBQ 48: NSC D-763303), Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/1573407210666141126204355
DOI https://dx.doi.org/10.2174/1573407210666141126204355 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthetic and Biological Attributes of Pyrimidine Derivatives: A Recent Update
Current Organic Synthesis Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Chemical and Genetic Engineering Strategies to Improve the Potency of Pharmaceutical Proteins and Enzymes
Current Medicinal Chemistry C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Current Medicinal Chemistry Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Subject Index to Volume 9
Current Pharmaceutical Design 3,4,5-Trisubstituted-1,2,4-triazole Derivatives as Antiproliferative Agents: Synthesis, In vitro Evaluation and Molecular Modelling
Letters in Drug Design & Discovery Stage N2/IIIA Non Small Cell Lung Cancer: An Evidence-Based Review
Current Cancer Therapy Reviews Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Efficient Gene Selection for Cancer Prognostic Biomarkers Using Swarm Optimization and Survival Analysis
Current Bioinformatics Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Current Gene Therapy Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment
Mini-Reviews in Medicinal Chemistry Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes
Current Medicinal Chemistry Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Current Pharmaceutical Design Pharmacodynamics of Radiolabelled Anticancer Drugs for Positron Emission Tomography
Current Pharmaceutical Design